Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells
Abstract Background In the era of personalized therapy, functional annotation of less frequent genetic aberrations will be instrumental in adapting effective therapeutic in clinic. Overexpression of Melanoma associated antigen A3 (MAGEA3) is reported in certain pancreatic cancer (PCA) patients. The...
Main Authors: | Biswajit Das, Shantibhusan Senapati |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1272-2 |
Similar Items
-
Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression
by: Yiu Huen Tsang, et al.
Published: (2020-04-01) -
MAGEA4 Coated Extracellular Vesicles Are Stable and Can Be Assembled In Vitro
by: Olavi Reinsalu, et al.
Published: (2021-05-01) -
Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma
by: Tang WW, et al.
Published: (2016-07-01) -
Knockdown of MAGEA6 Activates AMP-Activated Protein Kinase (AMPK) Signaling to Inhibit Human Renal Cell Carcinoma Cells
by: Xueting Ye, et al.
Published: (2018-02-01) -
Resveratrol acts via melanoma-associated antigen A12 (MAGEA12)/protein kinase B (Akt) signaling to inhibit the proliferation of oral squamous cell carcinoma cells
by: Yu Shang, et al.
Published: (2021-01-01)